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Introduction
Hyperacusis  is  known  as  an  abnormal  reduced  tolerance  to
environmental  sounds.1 Such  patients  describe  that  every-
day  sounds  are  too  loud  and  cause  them  discomfort  or  even
pain.
This  medical  condition  may  induce  a  strong  impact  on  the
quality  of  life  because  subjects  usually  avoid  common  situa-
tions,  such  as  social,  familiar  or  professional  interactions,
public  transport  and  walking  on  the  streets.
The  diagnosis  includes  a  history  of  intolerance  to  dif-
ferent  types  of  sounds  plus  decreased  thresholds  obtained
in  the  Loudness  Discomfort  Levels  (LDL)  or  Uncomfortable
Loudness  Levels  (ULL)  measured  at  least  to  500,  1000,  2000
and  4000  Hz.1,2
Hyperacusis  is  underestimated  among  children  and  ado-
lescents,  but  it  can  be  recognized  when  they  react  covering
their  ears,  crying,  screaming  or  leaving  the  place  when
they  are  exposed  to  television,  games,  conversation,  tele-
phone  calls,  home  appliances  (vacuum  cleaning,  washing
machines,  blender  and  others),  car  ride,  and  even  going  to
school.2
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access article under the CC BY license (http://creativecommons.org/licIn  children,  hyperacusis  has  been  associated  with
innitus.3 About  86%  of  hyperacusis  patients  perceive  tinni-
us  and  27--40%  of  tinnitus  patients  report  hyperacusis.4
Medication  is  rarely  described  for  treating  hyperacu-
is,  even  for  adults  but  especially  for  children/teenagers,
ecause  it  would  have  to  combine  safety  with  efﬁcacy.
here  is  no  drug  with  such  proved  qualities  so  far.  However,
harmacology  has  many  examples  of  drugs  that  are  used
or  further  indications  than  those  which  they  were  devel-
ped  for.  Thus,  we  considered  some  characteristics  of  the
inkgo  biloba  leaf  extract,  which  is  an  over-the-counter
erbal  medicine  widely  prescribed  for  managing  memory
nd  concentration  problems  in  different  ages,  depression,
nxiety,  dizziness,  and  tinnitus.5 When  it  was  targeted
or  managing  tinnitus,  a  commonly  associated  symptom,
.  biloba  proved  to  be  safe,6 although  its  efﬁcacy  was
ontroversial.7
Our  aim  is  to  describe  the  successful  treatment  of  two
ale  children  with  troublesome  hyperacusis  through  a  com-
ination  of  medication  plus  sound  enrichment.
ase reports
ase  1FB,  a  12  year-old  male,  came  for  the  ﬁrst  visit  in  February
013,  accompanied  by  his  mother.  He  complained  of  sound
ntolerance  to  the  voices  of  family,  friends  and  teachers,
 Cérvico-Facial. Published by Elsevier Editora Ltda. This is an open
enses/by/4.0/).
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Table  1  Hearing  thresholds  from  0.25  to  16  kHz  in  both  ears  in  the  4  exams  performed  between  March  2013  and  February  2014.
0.25  0.5  1  2  3  4  6  8  9  10  11.2  12.5  14  16
Right  hearing  thresholds  (kHz)
dBHL  in  March  2013  5  10  5  10  5  5  15  10  10  10  5  0  0  0
dBHL in  May  2013  5  5  0  5  10  5  10  10  10  5  5  5  0  0
dBHL in  August  2013  10  5  5  10  5  5  15  10  5  10  5  5  0  0
dBHL in  February  2014  5  10  5  5  5  10  10  5  5  5  5  0  0  0
Left hearing  thresholds  (kHz)
dBHL  in  March  2013  15  10  10  15  15  15  20  10  5  0  0  −5  0  0
dBHL in  May  2013  10  5  5  10  15  15  15  10  5  5  5  0  0  0
dBHL in  August  2013 10  10  5  10  5  10  10  5  5  5  5  0  0  0
dBHL in  February  2014 15  10  10  15  10  15  15  5  5  0  0  −5  5  0
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akHz, kilohertz; dBHL, decibel Hearing Level.
adio,  TV  and  trafﬁc.  At  school,  he  had  limitations  in  class,
specially  during  physical  education,  when  sports  activities
ere  practiced  indoors.  He  started  to  use  ear  protection
ll  day  long  and  to  spend  the  school  recess  in  the  silence
f  the  library.  Two  months  before  the  ﬁrst  visit,  he  com-
lained  about  a  constant  high-frequency  bilateral  tinnitus,
hich  made  the  family  search  for  medical  help.
Ear,  nose  and  throat  examination  was  normal.  The  initial
udiological  battery  included  hearing  thresholds  from  250
o  16,000  Hz,  Loudness  Discomfort  Levels  (LDL)  and  tinnitus
itch  and  loudness  matching  (Tables  1--3).
Treatment  was  composed  by:
 Counseling  using  an  easy  language,  including  the  deﬁnition
of  hyperacusis  and  tinnitus,  their  possible  etiologies  and
association,  as  well  as  the  need  to  decrease  the  constant
use  of  ear  protection,  which  is  likely  to  worsen  the  sound
intolerance.
 Use  of  environmental  low  level  sound  therapy  for  2--3  h
during  the  day  or  night.  However,  PFB  disagreed  because
he  was  afraid  of  withdrawing  ear  protection. Because  of  this  resistance,  we  prescribed  Gingko  biloba
extract  80  mg  twice  a  day  for  2  months  (24  mg  of  glicosides
Ginkgo-ﬂavonoids  and  6  mg  of  terpene  lactones),  based
on  previous  studies7,8 that  showed  its  safety  when  used
m
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Table  2  Loudness  Discomfort  Levels  obtained  from  0.5  to  4  kHz  
and February  2014.
0.5  
Right  LDL  (kHz)
dBHL  in  March  2013  65  
dBHL in  May  2013  65  
dBHL in  August  2013  65  
dBHL in  February  2014  65  
Left LDL  (kHz)
dBHL  in  March  2013  50  
dBHL in  May  2013  55  
dBHL in  August  2013  65  
dBHL in  February  2014  65  
LDL, Loudness Discomfort Levels; kHz, kilohertz; dBHL, decibel Hearinfor  vertigo  in  children  and  for  tinnitus  in  adults  (no  study
about  its  use  for  tinnitus  in  children  or  in  hyperacusis  was
found).  The  concomitant  use  of  environmental  sound,  as
mentioned  above,  was  reinforced.
In  May  2013,  PFB  came  again.  He  did  not  adhere  to  using
nvironmental  sound.  He  noticed  gradual  improvement  of
oth  tinnitus  and  hyperacusis  with  the  medication.  The  sec-
nd  audiological  battery  is  described  in  Tables  1--3.  Based
n  his  clinical  and  audiological  improvement,  we  suggested
o  keep  the  medication  for  a  further  three  months.
In  August  2013,  he  reported  greater  improvement  and
ventually  decreased  the  use  of  ear  protection.  He  stopped
oing  to  the  library  at  school  when  his  colleagues  were  going
o  the  recess.  Tinnitus  was  barely  perceived  for  a few  min-
tes  before  going  to  sleep.  The  third  audiological  battery  is
escribed  in  Tables  1--3.
Because  of  his  extra  clinical  and  audiological  improve-
ent,  as  well  as  his  mother’s  satisfaction  with  his  behavior
t  home  and  school,  we  withdrew  the  medication.  After  six
onths,  PFB  came  back  for  the  fourth  audiological  battery  in
ebruary  2014,  which  proved  that  his  improvement  in  both
innitus  and  hyperacusis  was  kept  stable  with  no  further
reatment  (Tables  1--3).
in  both  ears  in  the  4  exams  performed  between  March  2013
1  2  4
60  50  40
60  60  55
65  60  55
60  60  65
50  50  45
55  55  60
65  60  55
70  65  60
g Level.
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Table  3  Tinnitus  pitch  and  loudness  matching  obtained  in  the  4  exams  performed  between  March  2013  and  February  2014.
Tinnitus  pitch  (kHz)  Tinnitus  loudness  dBSL  Minimal  Masking  Level  dBSL
Right  Left  Right  Left  Right  Left
March  2013  12.5  12.5  18  16  24  23
May 2013  12.5  12.5  7  8  15  15
August 2013  12.5  12.5  2  4  6  8
February 2014  11.2  11.2  3  4  14  8
kHz, kilohertz; dBSL, decibel Sensation Level.
Table  4  Hearing  thresholds  from  0.25  to  8  kHz  in  both  ears  in  the  audiometry  brought  by  the  patient  and  performed  in  his  own
city.
Hearing  thresholds  (kHz)  0.25  0.5  1  2  3  4  6  8
Right  ear,  dBHL,  Nov  2012  10  10  10  5  5  5  5  5
Left ear,  dBHL,  Nov  2012  20  20  10  5  5  5  5  15
Table  5  Loudness  Discomfort  Levels  (LDL)  from  0.5  to  4  kHz  in  both  ears,  brought  by  the  patient  and  performed  in  his  own  city.
LDL  (kHz)  0.5  1  2  4
Right  ear,  dBHL,  Nov  2012 90  90  80  85
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rLeft ear,  dBHL,  Nov  2012 90  
Case  2
BGA,  an  11  year-old  male,  came  for  the  ﬁrst  visit  in
November  2013  accompanied  by  his  parents.  He  has  always
complained  of  sound  intolerance  to  many  sounds,  especially
for  the  last  8  months.  He  was  continuously  using  ear  pro-
tection  at  school,  street  and  home,  so  as  to  avoid  being
annoyed  with  the  voices  of  friends,  family,  school  colleagues
and  teachers,  as  well  as  the  trafﬁc  jam  and  snack  bars.  He
had  no  past  or  present  history  of  tinnitus.
Ear,  nose  and  throat  examination  was  normal.  His  audi-
ological  exam  showed  normal  bilateral  hearing  thresholds
from  250  to  8000  Hz  (Table  4),  with  LDL  ranging  from  80  to
90  dB  in  both  ears  (Table  5)  and  normal  acoustic  reﬂexes.
Due  to  the  previous  success  obtained  with  the  treatment
prescribed  to  the  patient  PFB,  which  will  be  discussed  later,
BGA  was  also  advised  to  use  Gingko  biloba  extract  plus  envi-
ronmental  sounds  for  3  months.  After  5  months  (May  2014),
parents  reported  that  they  noticed  an  improvement  in  his
behavior  when  facing  sounds  and  that  he  was  rarely  using
ear  protection.  We  recommended  him  to  keep  the  environ-
mental  sounds  at  night  and  to  decrease  the  G.  biloba  to  one
pill  a  day  for  another  month.
After  three  months  (August  2014),  his  mother  reported
that  BGA  was  able  to  enjoy  a  friend’s  birthday  party  for  the
ﬁrst  time  and  also  to  celebrate  his  own  birthday  with  friends
and  music.  Both  treatments  were  withdrawn.Discussion
Prevalence  studies  in  children  are  rare  and  results  varied
widely  from  2%  to  42%  with  clinical  complaint  of  hyperacusis,
i
l
p85  85  80
ut  just  3.2%  had  low  Loudness  Discomfort  Levels  (loudness
yperacusis).3,8
Both  cases  described  are  pre-adolescent  males  suffer-
ng  from  hyperacusis.  One  also  reported  tinnitus,  which  is
 common  association.3 Within  the  auditory  system,  abnor-
ally  high  neural  gain  may  result  in  higher  spontaneous
nd/or  stimulus-evoked  neural  ﬁring  rates,  resulting  in  tinn-
tus  and/or  sound  intolerance.9 Our  patient  with  tinnitus
ndeed  had  his  LDL  thresholds  worse  than  the  one  without
innitus.
A  key  point  for  the  diagnosis  is  the  measurement  of
LL  (Uncomfortable  Loudness  Levels)  or  LDL  (Loudness  Dis-
omfort  Levels),  but  the  verbal  instruction  made  by  the
udiologist  is  crucial  to  determine  reliable  values.  For  exam-
le,  different  results  of  ULL  for  asymptomatic  listeners
an  be  obtained  when  they  point  out  they  are  ‘‘slightly
ncomfortable’’  or  ‘‘deﬁnitively  uncomfortable’’  to  loud-
ess  levels.  In  normal-listener  young  adults,  the  LDL  varied
etween  86  and  98  dBHL  from  250  to  8000  Hz.2 The  follow-
ng  instruction  was  previously  suggested  and  was  followed  in
he  present  study:  ‘‘You  will  hear  sounds  that  will  become
ouder.  Please,  press  the  button/raise  your  hand  when  the
ound  reaches  an  intensity  that  you  no  longer  want  to  hear
t,  and  the  sound  will  stop  immediately.  We  want  to  know
hich  intensity  provokes  discomfort,  and  not  if  the  sound
s  strong  or  weak.  The  sound  can  be  strong  and  not  provoke
ny  hearing  discomfort,  for  example.  This  test  does  not  offer
isk  to  your  hearing  even  if  you  hear  a  sound  in  the  maximum
ntensity  of  this  equipment’’.
Due  to  the  heterogeneity  of  LDL  obtained  in  normal
isteners,  the  test  should  be  carefully  considered2;  if  the
atient  has  the  combination  of  clinical  complaint  about
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ound  intolerance  and  discomfort  thresholds  lower  than
5  dBHL,  the  diagnosis  of  hyperacusis  would  be  adequate.
Tinnitus  retraining  therapy  proposes  counseling  and
ound  therapy  to  manage  hyperacusis  and  tinnitus.  It  was
ecommended  for  both  patients,  but  only  BGA  performed  it
egularly  together  with  the  medication.  So,  its  role  in  the
uccess  of  the  treatment  of  hyperacusis  is  not  clear.
The  constant  use  of  ear  protection  is  a  common  attempt
o  prevent  further  discomfort  when  facing  unexpected
ounds,  especially  when  subjects  are  annoyed  by  many
ounds  or  when  they  have  to  move  around  areas  with  vary-
ng  noise  levels.10 Our  patients  were  using  overprotection
ll  day  long,  which  can  decrease  the  auditory  input  to  cen-
ral  auditory  pathways  and  induce  extra  hypersensitivity  to
ounds.  Therefore,  infants  and  parents  should  be  counseled
o  keep  the  protection  just  when  needed.
G.  biloba  extract  seems  to  have  inﬂuenced  the  improve-
ent  of  hyperacusis  in  both  cases.  The  rationale  to  use  it
n  the  ﬁrst  patient  was  the  presence  of  short-term  tinnitus,
he  lack  of  any  evidence  about  using  medication  for  tinnitus
n  children,  and  its  safety  in  adults.6 In  children  or  adoles-
ents,  it  is  used  for  attention-deﬁcit  hyperactivity  disorder,
yslexia,  and  dizziness,  among  others.
In  PFB’s  follow  up,  there  was  an  improvement  in  his
ehavior  and  in  his  measurements  of  LDL  and  tinnitus
oudness  matching.  So,  the  medication,  although  empir-
cally  tested,  was  able  to  partially  improve  tinnitus  and
yperacusis.  Thus,  as  a  natural  scientiﬁc  step  after  having
xplained  the  previous  experience  to  BGA’s  parents  and  hav-
ng  obtained  their  approval,  we  tried  the  same  schedule  for
GA  when  he  complained  of  hyperacusis  --  with  no  tinni-
us.  No  side  effects  were  reported,  in  agreement  with  the
iterature.
Medication  is  rarely  described  for  treating  hyperacusis
ecause  a  consistent  and  scientiﬁcally  proved  combination
f  safety  and  efﬁcacy  has  not  yet  been  described.  However,
harmacology  and  the  drug  market  have  many  examples
f  drugs  that  are  used  for  further  indications  than  those
hich  they  were  developed  to.  Some  stories  started  with
ncidental  ﬁndings  which,  in  case  of  being  well  proven,  may
llow  relief  for  a  greater  population.  Considering  that:  (A)  G.
iloba  leaf  extract  is  an  over-the-counter  herbal  medicine
idely  prescribed  for  managing  memory  and  concentration
roblems  in  different  ages,  depression,  anxiety,  dizziness,
nd  tinnitus5;  (B)  when  it  was  targeted  for  managing  tinni-
us,  a  commonly  associated  symptom,  G.  biloba  proved  to
e  safe6,7;  (C)  the  patient  PFB  had  tinnitus  together  with
yperacusis  and  the  degree  of  control  that  G.  biloba  pro-
oted  in  both  symptoms  was  surprising;  (D)  the  authors  of
he  present  report  routinely  explain  the  advantages  and  dis-
dvantages  of  treatments,  so  that  patients  and/or  parents
ave  a  participative  role  in  choosing  the  best  option  in  each
ase;  (E)  BGA’s  parents  decided  to  search  for  help  out  of
heir  country  due  to  the  severity  of  his  symptoms  and  the
ack  of  help  in  previous  attempts;  moreover,  they  were  ade-
uately  oriented  about  the  empiric  effects  of  G.  biloba  in
1 PRESS
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he  ﬁrst  patient  and  about  the  lack  of  other  scientiﬁc  evi-
ences  to  support  it;  with  such  information,  their  permission
as  given  to  try  to  use  the  same  medication,  this  time  in
rder  to  control  just  the  hyperacusis.  Despite  the  inherent
isk  taken  by  both  sides,  the  success  in  controlling  hypera-
usis  and  returning  quality  of  life  to  BGA  was  even  greater,
s  the  mother’s  emails  have  shown.
Medication  was  seldom  reported  for  hyperacusis,  even
n  adults:  alprazolam  (a  short-acting  anxiolytic),  carba-
azepine  (an  anticonvulsant  and  mood-stabilizing  drug)  or
ntidepressants  (ﬂuvoxamine  and  ﬂuoxetine).10 Our  reports
n  two  pre-adolescent  males  do  not  intend  to  afﬁrm  that
ingko  biloba  is  effective  for  managing  hyperacusis  and/or
innitus,  but  rather  to  be  a ﬁrst  step  and  allow  further  con-
iderations  for  future  controlled  studies.  If  conﬁrmed,  this
reatment  option  would  likely  increase  the  interest  of  Oto-
aryngologists  in  studying  and  treating  this  population.
onclusions
solated  or  in  association  with  the  environmental  sounds,
.  biloba  extract  contributed  to  dramatically  improve  the
estrictive  symptoms  of  sound  intolerance  in  two  pre-
dolescent  children.
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